Critical Reviews in Therapeutic Drug Carrier Systems

Begell House

Evaluation status available after sign-in

About the journal

Critical Reviews in Therapeutic Drug Carrier Systems is a journal published by Begell House in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Begell House
ISSN
2162-660X · 0743-4863
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 1984-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

619

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

87

i10-index

334

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
62%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Identity & continuity3
Alternate titles
C.R.C. critical reviews in therapeutic drug carrier systemsChemical Rubber Company critical reviews in therapeutic drug carrier systems
Source type
journal
NLM unique ID (PubMed)
8511159
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • RNA Interference and Gene Delivery
  • Drug Solubulity and Delivery Systems
  • RNA Interference and Gene Delivery
  • Drug Solubulity and Delivery Systems
Show all subjects (50)
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Lipid Membrane Structure and Behavior
  • Lipid Membrane Structure and Behavior
  • Inhalation and Respiratory Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Monoclonal and Polyclonal Antibodies Research
  • Computational Drug Discovery Methods
  • Monoclonal and Polyclonal Antibodies Research
  • Graphene and Nanomaterials Applications
  • Graphene and Nanomaterials Applications
  • Computational Drug Discovery Methods
  • 3D Printing in Biomedical Research
  • Protein purification and stability
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Protein purification and stability
  • 3D Printing in Biomedical Research
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Glycosylation and Glycoproteins Research
  • Cancer Research and Treatment
  • Cancer Research and Treatment
  • Glycosylation and Glycoproteins Research
  • Surfactants and Colloidal Systems
  • Cancer Treatment and Pharmacology
  • Dermatology and Skin Diseases
  • Surfactants and Colloidal Systems
  • Dermatology and Skin Diseases
  • Cancer Treatment and Pharmacology
  • Advanced Polymer Synthesis and Characterization
  • Advanced Polymer Synthesis and Characterization

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: